药品双通道背景下医药电商发展的困境研究
The Study on the Challenges of Pharmaceutical E-Commerce Development under the Dual-Channel Background
DOI: 10.12677/ecl.2025.1451329, PDF,   
作者: 蒋泽稀*:贵州大学医学院,贵州 贵阳;邬卫东#:贵州中医药大学人文与管理学院,贵州 贵阳
关键词: 药品双通道医药电商困境研究Dual-Channel Pharmaceuticals Pharmaceutical E-Commerce Challenge Research
摘要: 在“双通道”政策驱动下,医药电商成为药品供应体系改革的重要参与者,但其发展面临多维挑战。本研究从政策执行与市场竞争的角度,系统分析行业核心困境:其一,区域医保体系差异性与医院控费机制限制处方外流效率,导致跨区域服务成本高企;其二,冷链物流的高标准要求与集采药品利润压缩形成成本与效率的矛盾,制约基层市场覆盖能力;其三,寡头垄断格局与传统药店即时配送服务的竞争挤压中小企业生存空间;其四,专业药师服务能力不足与数据安全隐患降低患者信任度,影响处方药线上化进程。研究提出,需通过区域资质互认、智能物流技术应用以及垂直细分市场深耕等策略,协同政策资源与市场力量,优化行业生态。本文为医疗政策与数字经济融合的实践矛盾提供分析框架,并为医药电商可持续发展路径提供政策启示。
Abstract: Driven by the “dual-channel” policy, pharmaceutical e-commerce has become an important participant in the reform of the drug supply system; however, its development faces multidimensional challenges. This study systematically analyzes the core dilemmas of the industry from the perspectives of policy implementation and market competition. First, the disparities in regional medical insurance systems and the cost control mechanisms of hospitals restrict the efficiency of prescription outflow, resulting in high cross-regional service costs. Second, the high standards required for cold chain logistics and the profit compression of centralized procurement drugs create a contradiction between cost and efficiency, limiting the market coverage capability at the grassroots level. Third, the oligopolistic monopoly pattern and competition from traditional pharmacy instant delivery services squeeze the survival space of small and medium-sized enterprises. Fourth, insufficient professional pharmaceutical service capabilities and data security risks reduce patient trust, impacting the online process of prescription drugs. The study proposes that strategies such as mutual recognition of regional qualifications, the application of intelligent logistics technology, and deep cultivation of vertical niche markets are needed to synergize policy resources and market forces, optimizing the industry ecosystem. This paper provides an analytical framework for the practical contradictions between healthcare policy and digital economy integration, and offers policy insights for the sustainable development path of pharmaceutical e-commerce.
文章引用:蒋泽稀, 邬卫东. 药品双通道背景下医药电商发展的困境研究[J]. 电子商务评论, 2025, 14(5): 686-691. https://doi.org/10.12677/ecl.2025.1451329

参考文献

[1] 徐鑫, 王守涛, 杨郁葱. 医保谈判药“双通道”政策管理模式及优化建议[J]. 中国医院, 2023, 27(9): 75-77.
[2] 张雨晨, 吴烨, 周典, 等. 国谈药品“双通道”建设路径与优化机制研究[J]. 中国医院, 2025, 29(2): 11-15.
[3] 孟令全, 刘志刚, 施伯琰, 等. 美国医药电子商务发展情况及其对我国的启示[J]. 中国药房, 2006, 17(7): 551-553.
[4] 王德娇. 医药电商商业模式研究[D]: [硕士学位论文]. 开封: 河南大学, 2024.
[5] 赵敏, 原超, 李朝霞. 大数据背景下医药电子商务服务模式的提升与探究[J]. 山西经济管理干部学院学报, 2018, 26(1): 45-48.
[6] 杜洪伟. B2C模式下医药电商平台用户满意度研究[D]: [硕士学位论文]. 天津: 天津财经大学, 2020.
[7] 周泰. O2O模式下医药产品捆绑定价及即时配送决策研究[D]: [博士学位论文]. 武汉: 华中科技大学, 2019.
[8] 何贤英, 孙东旭, 王琳琳, 等. “互联网+”背景下医药电商服务体系构建研究[J]. 中国卫生事业管理, 2021, 38(4): 241-243, 247.
[9] 侯文华, 杨丹丹. 电子商务背景下我国医药供应链创新发展研究[J]. 现代管理科学, 2019(3): 3-5.